Dr. Heller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
National Institutes of Health, Translational Hepatology Section
10 Center Drive, MSC 1800
Bethesda, MD 20892Phone+1 301-496-1721Fax+1 301-402-0491- Is this information wrong?
Education & Training
- University of MarylandFellowship, Gastroenterology, 1997 - 2000
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1990 - 1993
- University of the WitwatersrandClass of 1989
Certifications & Licensure
- MD State Medical License 1992 - 2024
Clinical Trials
- Immune Response to Hepatitis C Virus Start of enrollment: 2000 Sep 24
- Pegylated Interferon to Treat Chronic Hepatitis D Start of enrollment: 2001 Aug 01
- Lonafarnib for Chronic Hepatitis D Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- Hepatology consultation is associated with decreased early return to alcohol use after discharge from an inpatient alcohol use disorder treatment program.Hanna L Blaney, Mian B Khalid, Alexander H Yang, Natasha Kamal, Elizabeth C Wright, Tomilowo Abijo, Chris Koh, David George, David Goldman, Yvonne Horneffer, Bilal A A...> ;Hepatology Communications. 2024 May 1
- HDV: Epidemiology, lifecycle, testing, and treatment.Kareen L Akiva, Christopher Koh, Theo Heller> ;Clinical Liver Disease. 2024 Apr 15
- Granulomatous liver diseases.Maria Mironova, Harish Gopalakrishna, Gian Rodriguez Franco, Christopher Koh, Steven M Holland, David E Kleiner, Theo Heller> ;Hepatology Communications. 2024 Apr 1
- Join now to see all
Journal Articles
- Characterization of the Hepatosplenic and Portal Venous Findings in Patients with Proteus SyndromeTheo Heller, MD, American Journal of Medical Genetics Part A
- Rheological Determinants for Simultaneous Staging of Hepatic Fibrosis and Inflammation in Patients with Chronic Liver DiseaseAhmed M Gharib, Theo Heller, NMR in Biomedicine
Press Mentions
- FDA Summit on Gene Therapy Risks Proves TimelySeptember 7th, 2021
- At FDA Meeting, Gene Therapy Experts Wrestle with Field's BlindspotsSeptember 3rd, 2021
- Liver Toxicity in Gene Therapy Trials Could Merit Stricter Entry CriteriaSeptember 3rd, 2021
Hospital Affiliations
- NIH Clinical CenterBethesda, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: